子宫内膜癌组织中Bim蛋白表达及其临床意义

Expression of Bim in Endometrial Carcinoma and Its Clinical Significances

  • 摘要: 目的:探讨促凋亡基因Bim在子宫内膜癌发生与发展中的作用。方法:应用免疫组化SP方法检测11例正常增殖期子宫内膜、13例非典型增生子宫内膜及55例子宫内膜癌Bim蛋白的表达。结果:在子宫内膜癌组织Bim表达阳性率为47.2%, 明显低于正常增殖期内膜组织(100%)及非典型增生内膜组织(76.9%), 三者之间比较有显著差异(X2=7.944, P<0.05)。而在子宫内膜癌各组织分级、临床分期及肌层浸润程度之间, Bim蛋白表达阳性率均无明显差异(P>0.05)。结论:Bim蛋白表达改变与子宫内膜癌的发生密切相关。

     

    Abstract: Objective:To study the effect of Bim on the genesis and progression of endometrial carcinoma. Methods: Expression of Bim was evaluated by immunohistochemistry (SP) in 55 cases of endometrial carcinoma, 13 ('uses of atypical hyperplasia endometrium and 11 (uses of normal prolifera-tive stage endometrium. Results: The positive rate of Bim expression in endometrial carcinoma is 47.2%, which is lower than that 7n 7n normal proliferative endometrium (100%) and that in perplasia endometrium (76.9%). The difference betweenthere is no difference among different histological gradesthem is significant (X2=7.944, atypical hy-P<0.05), but, clinical stages and muscle invasions of endometrial carcinoma (P>0.05). Conclusions: There endometrial carcinoma and the change of expression is a close relationship between the occurrence of Rim.

     

/

返回文章
返回